Stay updated on Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3. This appears to be a minor internal update with no user-facing changes to the Study Details page.
    Difference
    0.0%
    Check dated 2026-03-11T15:55:44.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Cosmetic UI/Layout changes observed with no modification to core study details or outcomes.
    Difference
    0.0%
    Check dated 2026-03-04T11:51:11.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag was added. A non-critical funding/operating status notice was removed; core trial content and page functionality remain unchanged.
    Difference
    0.2%
    Check dated 2026-02-11T02:35:20.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operating status was added, and the site revision was updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-03T23:53:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    UI and metadata updates include showing a glossary option and adding metadata fields such as Results First Posted, Certification/Extension First Posted, Last Update Submitted that Met QC Criteria, and Last Update Posted, with the revision noted as v3.4.0; older related fields were removed.
    Difference
    0.2%
    Check dated 2026-01-28T00:30:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no user-facing study details appear to be affected.
    Difference
    0.0%
    Check dated 2026-01-14T02:04:59.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.